S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
One year after buying a failed bank, New York Community Bancorp is struggling
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Critical asset just had biggest fall on record (Ad)
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
One year after buying a failed bank, New York Community Bancorp is struggling
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Critical asset just had biggest fall on record (Ad)
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
One year after buying a failed bank, New York Community Bancorp is struggling
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Critical asset just had biggest fall on record (Ad)
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
One year after buying a failed bank, New York Community Bancorp is struggling
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Friday, 3/1/2024
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Critical asset just had biggest fall on record (Ad)
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches

Nkarta (NKTX) News Today

$12.84
+0.76 (+6.29%)
(As of 03/1/2024 ET)
SourceHeadline
marketbeat.com logoNkarta (NASDAQ:NKTX) Shares Gap Up to $12.08
marketbeat.com - March 1 at 11:40 AM
investorplace.com logo3 Silent Tech Titans-in-the-Making: Invest Before They Skyrocket
investorplace.com - February 29 at 6:30 AM
globenewswire.com logoNkarta to Participate in Upcoming Investor Conferences
globenewswire.com - February 28 at 8:01 AM
benzinga.com logoNkarta Stock (NASDAQ:NKTX), Short Interest Report
benzinga.com - February 22 at 9:39 AM
investorplace.com logoLast Call! 7 Small-Cap Stocks Ready to Explode in Value
investorplace.com - February 20 at 4:19 PM
marketbeat.com logoNkarta (NASDAQ:NKTX) Sets New 12-Month High at $12.20
marketbeat.com - February 12 at 10:53 AM
marketbeat.com logoInnovis Asset Management LLC Invests $193,000 in Nkarta, Inc. (NASDAQ:NKTX)
marketbeat.com - February 9 at 3:14 PM
markets.businessinsider.com logo3 Sleeper Stocks With Serious Potential to Make You a Millionaire
markets.businessinsider.com - February 6 at 1:22 PM
seekingalpha.com logoNkarta: Possible Upside From H1 Update, If Positive
seekingalpha.com - January 25 at 6:32 PM
marketbeat.com logoInsider Selling: Nkarta, Inc. (NASDAQ:NKTX) Insider Sells 3,552 Shares of Stock
marketbeat.com - January 18 at 7:24 PM
marketbeat.com logoNkarta, Inc. Forecasted to Earn FY2024 Earnings of ($2.47) Per Share (NASDAQ:NKTX)
marketbeat.com - January 18 at 7:47 AM
marketbeat.com logoEquities Analysts Set Expectations for Nkarta, Inc.'s FY2028 Earnings (NASDAQ:NKTX)
marketbeat.com - January 17 at 8:13 AM
marketbeat.com logoNkarta (NASDAQ:NKTX) Price Target Raised to $22.00
marketbeat.com - January 16 at 4:24 PM
finance.yahoo.com logoNkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains
finance.yahoo.com - January 16 at 8:22 AM
markets.businessinsider.com logoNkarta’s Promising CAR-NK Cell Therapies: A ‘Buy’ Rating Reinforced by Robust Clinical Data and Strategic Advancements
markets.businessinsider.com - January 11 at 10:07 AM
markets.businessinsider.com logoBuy Rating Reiterated for Nkarta Amid Promising Redosing Results and Broad Therapeutic Potential
markets.businessinsider.com - January 9 at 3:09 PM
msn.com logoWhat's Going On With Cancer Drug-Developer Nkarta Stock?
msn.com - January 8 at 6:40 PM
benzinga.com logoNkarta Stock (NASDAQ:NKTX) Dividends: History, Yield and Dates
benzinga.com - December 28 at 7:31 AM
benzinga.com logoNkarta Stock (NASDAQ:NKTX) Insider Trades
benzinga.com - December 27 at 10:00 AM
markets.businessinsider.com logoPositive Clinical Updates Reinforce Buy Rating for Nkarta’s Cellular Therapy Programs
markets.businessinsider.com - December 13 at 8:16 AM
markets.businessinsider.com logoAnalyst Ratings for Nkarta
markets.businessinsider.com - December 12 at 10:22 AM
markets.businessinsider.com logoBuy Rating on Nkarta’s Stock Upheld Amid Promising NKX101 Clinical Data and Potential AML Treatment Breakthrough
markets.businessinsider.com - December 12 at 5:22 AM
finance.yahoo.com logoNkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
finance.yahoo.com - December 10 at 1:12 AM
seekingalpha.com logoNkarta: Trying To Be The NK Story That Actually Succeeds
seekingalpha.com - December 3 at 9:07 AM
finance.yahoo.com logoT. Rowe Price Investment Management, Inc. Reduces Stake in Nkarta Inc
finance.yahoo.com - November 14 at 8:21 PM
benzinga.com logoSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Nkarta, Inc. (NASDAQ: NKTX) and Encourages Investors to Contact the Firm
benzinga.com - November 11 at 12:30 PM
markets.businessinsider.com logoPromising Developments and Financial Stability Propel Nkarta’s Buy Rating: An Insight into Expansion, Upcoming Trials, and Financial Position
markets.businessinsider.com - November 10 at 8:51 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Nkarta (NKTX), Adaptimmune Therapeutics (ADAP) and Corvus Pharmaceuticals (CRVS)
markets.businessinsider.com - November 10 at 8:51 PM
finanznachrichten.de logoNkarta, Inc.: Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
finanznachrichten.de - November 10 at 10:16 AM
finance.yahoo.com logoNkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights
finance.yahoo.com - November 9 at 6:45 PM
msn.com logoRaymond James Upgrades Nkarta (NKTX)
msn.com - October 18 at 8:07 PM
finance.yahoo.com logoNkarta (NKTX) Rallies 112% as FDA Clears IND for Lupus Drug
finance.yahoo.com - October 18 at 1:54 PM
msn.com logoNkarta upgraded to strong buy by Raymond James
msn.com - October 17 at 8:57 PM
msn.com logoNkarta stock jumps 20% on FDA, cash runway extension updates
msn.com - October 17 at 8:57 PM
bizjournals.com logoPeninsula biotech's stock soars as it cuts staff, focuses cell therapy on autoimmune diseases
bizjournals.com - October 17 at 8:57 PM
markets.businessinsider.com logoPositive Outlook for Nkarta: FDA Approvals, Cost Reduction Initiatives, and Promising Expansion into Autoimmune Disease Treatment
markets.businessinsider.com - October 17 at 8:57 PM
benzinga.com logoNkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis
benzinga.com - October 17 at 3:49 PM
msn.com logoWhat's Going With Cancer-Focused Nkarta Stock Today?
msn.com - October 17 at 3:49 PM
markets.businessinsider.com logoNkarta’s Promising Pipeline Expansion and Cost-Saving Measures Drive Analyst’s Buy Rating
markets.businessinsider.com - October 17 at 3:49 PM
finance.yahoo.com logoLupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus Nephritis
finance.yahoo.com - October 17 at 3:49 PM
finanznachrichten.de logoNkarta, Inc.: Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis
finanznachrichten.de - October 17 at 8:01 AM
markets.businessinsider.com logoNkarta Says FDA Clears IND Application For NKX019 To Treat Lupus Nephritis
markets.businessinsider.com - October 17 at 8:01 AM
finance.yahoo.com logoNkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures
finance.yahoo.com - October 16 at 4:19 PM
finance.yahoo.com logoIs Nkarta (NASDAQ:NKTX) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - October 16 at 9:47 AM
markets.businessinsider.com logoVentyx Biosciences Announces Positive Results From Trial Of VTX002 For Ulcerative Colitis
markets.businessinsider.com - October 9 at 6:16 PM
markets.businessinsider.com logoPromising Prospects for Ventyx Biosciences: A Comprehensive Analysis of VTX002’s Potential in Ulcerative Colitis Treatment
markets.businessinsider.com - September 28 at 5:55 PM
benzinga.com logoNkarta Stock (NASDAQ:NKTX), Analyst Ratings, Price Targets, Predictions
benzinga.com - September 9 at 6:21 PM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Nkarta (NKTX) and Ventyx Biosciences (VTYX)
markets.businessinsider.com - August 14 at 6:19 PM
nasdaq.com logoMizuho Maintains Nkarta (NKTX) Buy Recommendation
nasdaq.com - August 14 at 6:19 PM
msn.com logoHC Wainwright & Co. Reiterates Nkarta (NKTX) Buy Recommendation
msn.com - August 11 at 5:11 PM
Get Nkarta News Delivered to You Automatically

Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter.



NKTX Media Mentions By Week

NKTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NKTX
News Sentiment

0.98

0.62

Average
Medical
News Sentiment

NKTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NKTX Articles
This Week

4

1

NKTX Articles
Average Week

Get Nkarta News Delivered to You Automatically

Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:NKTX) was last updated on 3/2/2024 by MarketBeat.com Staff